3.連結財務諸表及び主な注記
(1)連結貸借対照表
| | (単位:千円) |
| 前連結会計年度 (2023年12月31日) | 当連結会計年度 (2024年12月31日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 4,392,845 | 6,317,961 |
受取手形 | 171,377 | 95,455 |
電子記録債権 | 1,352,309 | 1,199,515 |
売掛金 | 1,904,229 | 1,867,830 |
商品及び製品 | 2,376,010 | 2,091,024 |
仕掛品 | 889,199 | 774,771 |
原材料及び貯蔵品 | 1,049,028 | 1,055,435 |
その他 | 591,707 | 544,346 |
貸倒引当金 | △3,823 | △5,959 |
流動資産合計 | 12,722,884 | 13,940,381 |
固定資産 | | |
有形固定資産 | | |
建物及び構築物(純額) | 2,456,900 | 2,544,199 |
機械装置及び運搬具(純額) | 473,412 | 473,301 |
土地 | 1,643,472 | 1,086,223 |
建設仮勘定 | 293,057 | 191,330 |
その他(純額) | 522,630 | 548,757 |
有形固定資産合計 | 5,389,472 | 4,843,812 |
無形固定資産 | | |
借地権 | 168,602 | 177,874 |
その他 | 397,085 | 354,200 |
無形固定資産合計 | 565,687 | 532,075 |
投資その他の資産 | | |
投資有価証券 | 454,250 | 619,533 |
繰延税金資産 | 85,429 | 71,848 |
その他 | 41,053 | 40,016 |
投資その他の資産合計 | 580,732 | 731,398 |
固定資産合計 | 6,535,892 | 6,107,287 |
資産合計 | 19,258,777 | 20,047,668 |
| | (単位:千円) |
| 前連結会計年度 (2023年12月31日) | 当連結会計年度 (2024年12月31日) |
負債の部 | | |
流動負債 | | |
支払手形及び買掛金 | 498,848 | 534,773 |
電子記録債務 | 288,789 | 248,718 |
短期借入金 | 800,000 | 800,000 |
未払法人税等 | 84,609 | 83,522 |
賞与引当金 | 52,234 | 53,166 |
役員賞与引当金 | 16,015 | 12,096 |
前受金 | 86,500 | - |
その他 | 1,140,174 | 1,372,829 |
流動負債合計 | 2,967,172 | 3,105,107 |
固定負債 | | |
退職給付に係る負債 | 1,004,646 | 836,307 |
繰延税金負債 | 216,410 | 261,637 |
資産除去債務 | 2,701 | 2,702 |
長期未払金 | 34,858 | 28,086 |
その他 | 88,622 | 63,154 |
固定負債合計 | 1,347,239 | 1,191,888 |
負債合計 | 4,314,411 | 4,296,996 |
純資産の部 | | |
株主資本 | | |
資本金 | 1,461,735 | 1,461,735 |
資本剰余金 | 1,486,401 | 1,486,572 |
利益剰余金 | 10,586,341 | 11,078,119 |
自己株式 | △506,097 | △1,003,042 |
株主資本合計 | 13,028,380 | 13,023,385 |
その他の包括利益累計額 | | |
その他有価証券評価差額金 | 77,361 | 129,621 |
繰延ヘッジ損益 | - | 6,703 |
為替換算調整勘定 | 1,735,540 | 2,380,450 |
退職給付に係る調整累計額 | 103,083 | 210,512 |
その他の包括利益累計額合計 | 1,915,985 | 2,727,287 |
純資産合計 | 14,944,365 | 15,750,672 |
負債純資産合計 | 19,258,777 | 20,047,668 |
E0241651870クリエートメディック株式会社CREATE MEDIC CO.,LTD.通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2024-01-012024-12-31FY2024-12-312023-01-012023-12-312023-12-311falsefalsefalse518702024-01-012024-12-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember518702024-12-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember518702023-12-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember518702024-12-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember518702024-12-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember518702024-01-012024-12-31jppfs_cor:ShareholdersEquityMember518702024-01-012024-12-31jppfs_cor:CapitalStockMember518702024-01-012024-12-31jppfs_cor:CapitalSurplusMember518702024-01-012024-12-31jppfs_cor:RetainedEarningsMember518702024-01-012024-12-31jppfs_cor:TreasuryStockMember518702024-01-012024-12-31jppfs_cor:ValuationAndTranslationAdjustmentsMember518702024-01-012024-12-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember518702024-01-012024-12-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember518702024-12-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember518702024-01-012024-12-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember518702023-12-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember518702023-01-012023-12-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember518702022-12-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember518702022-12-31jppfs_cor:CapitalStockMember518702022-12-31jppfs_cor:CapitalSurplusMember518702022-12-31jppfs_cor:RetainedEarningsMember518702022-12-31jppfs_cor:TreasuryStockMember518702022-12-31jppfs_cor:ShareholdersEquityMember518702023-01-012023-12-31jppfs_cor:RetainedEarningsMember518702022-12-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember518702022-12-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember518702022-12-31jppfs_cor:ValuationAndTranslationAdjustmentsMember518702023-01-012023-12-31jppfs_cor:CapitalStockMember518702023-01-012023-12-31jppfs_cor:CapitalSurplusMember518702023-01-012023-12-31jppfs_cor:TreasuryStockMember518702023-01-012023-12-31jppfs_cor:ShareholdersEquityMember518702023-01-012023-12-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember518702023-01-012023-12-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember518702023-01-012023-12-31jppfs_cor:ValuationAndTranslationAdjustmentsMember518702023-12-31jppfs_cor:CapitalStockMember518702023-12-31jppfs_cor:CapitalSurplusMember518702023-12-31jppfs_cor:RetainedEarningsMember518702023-12-31jppfs_cor:TreasuryStockMember518702023-12-31jppfs_cor:ShareholdersEquityMember518702023-12-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember518702023-12-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember518702023-12-31jppfs_cor:ValuationAndTranslationAdjustmentsMember518702024-12-31jppfs_cor:ShareholdersEquityMember518702024-12-31jppfs_cor:CapitalStockMember518702024-12-31jppfs_cor:CapitalSurplusMember518702024-12-31jppfs_cor:RetainedEarningsMember518702024-12-31jppfs_cor:TreasuryStockMember518702024-12-31jppfs_cor:ValuationAndTranslationAdjustmentsMember518702024-01-012024-12-31518702025-02-13518702024-12-31518702023-12-31518702023-01-012023-12-31518702022-12-31iso4217:JPYxbrli:pure